United Therapeutics saw the highest growth of 332% in patent filings and 49% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 332% and grants by 49%. GlobalData’s DataBook provides a comprehensive analysis of United Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

United Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with nine publications in Q1 2024

The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 20% of filings. The European Patent Office(EPO), United States(US), South Korea(KR), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where United Therapeutics is filings its patents. Among the top granted patent authorities, United Therapeutics has 25% of its grants in United States(US) and 25% in Israel(IL).

Bayer could be the strongest competitor for United Therapeutics

In terms of grant share, United Therapeutics stands in tenth position among its competitors. Bayer and United Therapeutics secured the top positions according to recent patent publication data.

Patents related to 3d printing and cell & gene therapy lead United Therapeutics's portfolio

United Therapeutics has the highest number of patents in 3d printing followed by, cell & gene therapy and industrial automation. For 3d printing, nearly 49% of patents were filed and no patents were granted in Q1 2024.

Petrochemicals related patents lead United Therapeutics portfolio followed by pulmonary hypertension, and paints and inks

United Therapeutics has highest number of patents in petrochemicals followed by pulmonary hypertension, paints and inks, image management, and printing inks.

For comprehensive analysis of United Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.